In-Stent Restenosis Post-Approval Study
Public ClinicalTrials.gov record NCT02542267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Study identification
- NCT ID
- NCT02542267
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- W.L.Gore & Associates
- Industry
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
- Gore VIABAHN Endoprosthesis Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2015
- Primary completion
- Jun 30, 2019
- Completion
- Jun 30, 2021
- Last update posted
- Oct 15, 2023
2015 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mount Sinai Medical Center | Miami | Florida | 33140 | — |
| Kaiser Foundation Hospital | Honolulu | Hawaii | 96819 | — |
| Rockford CardioVascular Associates | Rockford | Illinois | 61107 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Cardiovascular Institute of the South | Houma | Louisiana | 70360 | — |
| Covenant Medical Center, Inc. | Saginaw | Michigan | 48602 | — |
| Munson Medical Center | Traverse City | Michigan | 49684 | — |
| Midwest Aortic and Vascular Institute (MAVI) | North Kansas City | Missouri | 64116 | — |
| New York University Langone Medical Center | New York | New York | 10016 | — |
| New York Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | 10065 | — |
| North Carolina Heart and Vascular | Raleigh | North Carolina | 27607 | — |
| Sanford Health | Fargo | North Dakota | 58122 | — |
| Providence Heart Clinic | Portland | Oregon | 97225 | — |
| St. Vincent's Consultants in Cardiovascular Disease | Erie | Pennsylvania | 16502 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| Greenville Hospital System | Greenville | South Carolina | 29615 | — |
| Texas Health Research - Presbyterian Heart and Vascular | Dallas | Texas | 75231 | — |
| Texas Health Research - Presbyterian Hospital of Plano | Plano | Texas | 75093 | — |
| Swedish Medical Center - Heart and Vascular Research | Seattle | Washington | 98122 | — |
| Charleston Area Medical Center | Charleston | West Virginia | 25304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02542267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2023 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02542267 live on ClinicalTrials.gov.